![]() |
|||
|
|
|
|
| UPDATE: May 2008 | MW: 144.62 | MF: C6H8N2•ClH |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
DNA repair
|
mouse
liver
|
10 µmol/L
|
JJCREP 79,204,1988
|
DNA repair
|
rat
liver
|
10 µmol/L
|
JJCREP 79,204,1988
|
mutation in microorganisms
|
Salmonella typhimurium
|
800 µg/plate (+/-enzymatic activation step)
|
NEZAAQ 33,474,1978
|
mutation in microorganisms
|
Salmonella typhimurium
|
252 µg/plate/72 hour (+enzymatic activation step)
|
MUTAEX 15,495,2000
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lowest published toxic dose: 30 mg/kg (17-19 day pregnant)
|
Reproductive: Effects on newborn: Behavioral
|
SEIJBO 14,95,1974
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 464 mg/kg/8 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Tumors
JNCIAM 42,337,1969
|
oral | mouse
lowest published toxic dose: 8,000 mg/kg/42 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Lung, Thorax, or Respiration: Tumors
34ZRA9 -,869,1965
|
oral | mouse
toxic dose : 10 gm/kg/58 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Vascular: Tumors Blood: Lymphoma including Hodgkin's disease
ZKKOBW 87,267,1976
|
oral | mouse
toxic dose : 928 mg/kg/8 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Tumors
JNCIAM 42,337,1969
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lethal dose (50 percent kill): 161 mg/kg
|
N/R
|
ABMGAJ 18,617,1967
|
intravenous | mouse
lethal dose (50 percent kill): 900 µg/kg
|
N/R
|
QJDRAZ 9,1455,1969
|
oral | mouse
lethal dose (50 percent kill): 2,100 mg/kg
|
N/R
|
QJDRAZ 9,1455,1969
|
oral | rabbit
lowest published lethal dose: 25 mg/kg
|
N/R
|
HBAMAK 4,1289,1935
|
subcutaneous | mouse
lethal dose (50 percent kill): 89 mg/kg
|
N/R
|
FRPSAX 9,274,1954
|
subcutaneous | rabbit
lowest published lethal dose: 25 mg/kg
|
N/R
|
HBAMAK 4,1289,1935
|
skin | rabbit
lowest published lethal dose: 500 mg/kg
|
Lung, Thorax, or Respiration: Cyanosis | Skin: After topical application: Corrosive Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FAATDF 8,583,1987
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
MUREAV 584,1,2005
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.1 mg/m3, JUN2003
|
| |||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO HYDRAZINES-air
|
Carcinogen ceiling concentration 0.03 ppm/120 minute
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 81928; | Number of Industries 2; Total Number of Facilities 115; Number of Occupations 5; Total Number of Employees Exposed 1,708
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 81928 |
Number of Industries 3; Total Number of Facilities 63; Number of Occupations 4; Total Number of Employees Exposed 645; Total Number of Female Employees Exposed 445 | ||||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
| ||||
REFERENCES:
CODEN
|
|
REFERENCE
34ZRA9
|
"Proceedings of the Quadrennial Conference on Cancer, 3rd, 1965," Severi, L., ed., Perugia,
Italy, Univ. of Perugia, 1966
|
ABMGAJ
|
Acta Biologica et Medica Germanica. (Berlin, Ger. Dem. Rep.) V.1-41, 1958-82. For publisher
information, see BBIADT.
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FRPSAX
|
Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88
For publisher information, see FRMCE8
|
HBAMAK
|
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.)
|
JJCREP
|
Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam,
Netherlands) V.76- 1985-
|
JNCIAM
|
Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher
information, see JJIND8.
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NEZAAQ
|
Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto
Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
QJDRAZ
|
Quarterly Journal of Crude Drug Research. (Lisse, Netherlands) V.1-19, 1961-81. For
publisher information, see IJCREE.
|
SEIJBO
|
Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu
Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26,
1960-86. For publisher information, see CGANE7.
|
ZKKOBW
|
Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92,
1971-78. For publisher information, see JCROD7.
|
| |